Jonathan P. Foster is CFO at Moleculin Biotech, Inc. (MBRX). They have made 7 open-market trades across 2 companies since 2014, most recently 2026-08-03.
CIK 0001545414
7 open-market purchases totalling $260K since 2014, never a sale. Across 7 scored buys the stock is up 15.2% at ninety days, and 11.8 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 71% | 86% |
| Avg Move | -2.7% | +15.2% | +15.2% |
| Alpha | +0.2% | +13.8% | +11.8% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MBRX | BUY | 2025-06-23 | 2025-06-23 | $0.37 | $200K | +19.3% | +148.7% | +43.3% |
| MBRX | BUY | 2023-12-26 | 2023-12-27 | $0.69 | $20K | -4.0% | -35.2% | -58.4% |
| MBRX | BUY | 2017-04-25 | 2017-04-26 | $0.86 | $9K | -12.4% | -11.4% | +117.3% |
| INFU | BUY | 2015-08-18 | 2015-08-18 | $2.92 | $3K | -5.4% | +1.0% | +1.0% |
| INFU | BUY | 2015-06-15 | 2015-06-17 | $3.12 | $973 | -5.4% | +1.0% | +1.0% |
| INFU | BUY | 2015-05-15 | 2015-05-18 | $3.07 | $13K | -5.4% | +1.0% | +1.0% |
| INFU | BUY | 2014-03-13 | 2014-03-14 | $2.78 | $14K | -5.4% | +1.0% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.